Aegerion Pharmaceuticals (AEGR)

Add to Watchlists Create an Alert
60.09 -0.87  -1.43%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

Aegerion Pharmaceuticals Revenue Quarterly:

1.231M for March 31, 2013
View Full Chart

Aegerion Pharmaceuticals Revenue Quarterly Chart

    Aegerion Pharmaceuticals Historical Revenue Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 1.231M
    Dec. 31, 2012 0.00
    Sept. 30, 2012 0.00
    June 30, 2012 0.00
    March 31, 2012 0.00
    Dec. 31, 2011 0.00
    Sept. 30, 2011 0.00
    June 30, 2011 0.00
    March 31, 2011 0.00
       
    Dec. 31, 2010 0.00
    Sept. 30, 2010 0.00
    June 30, 2010 0.00
    March 31, 2010 0.00
    Dec. 31, 2009 0.00
    Sept. 30, 2009 0.00
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    March 31, 2006 Go Pro

    About Revenues

    Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.

    While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
    Learn More

    Get data for

    AEGR Revenue Quarterly Benchmarks

    Companies
    Sanofi 10.45B
    Isis Pharmaceuticals 43.36M
    Keryx Biopharmaceuticals 0.00

    AEGR Revenue Quarterly Rankings

    Overall 38th percentile
    4660 of 7600
    Sector 33rd percentile
    434 of 653 in Healthcare
    Industry 39th percentile
    40 of 66 in Drug Manufacturers - Specialty & Generic

    AEGR Revenue Quarterly Range, Past 5 Years

    Minimum 0.00 Sep 2009
    Maximum 1.231M Mar 2013
    Average 0.0821M